malondialdehyde has been researched along with exendin (9-39) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, G; Hu, X; Jiang, H; Zhang, Y | 1 |
1 other study(ies) available for malondialdehyde and exendin (9-39)
| Article | Year |
|---|---|
Exendin-4 attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression.
Topics: Animals; Creatine Kinase; Cytoprotection; Disease Models, Animal; Down-Regulation; Exenatide; Glucagon-Like Peptide-1 Receptor; HMGB1 Protein; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Superoxide Dismutase; Time Factors; Venoms | 2013 |